Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 08 tags : Clinical-trials-phase-ii save search
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1/2 Clinical Trial Evaluating Gene Therapy Candidate OCU400
Published: 2021-11-08 (Crawled : 18:00) - biospace.com/
OCGN | News A | $1.3 -1.52% 4.3M
|
Health Technology
|
| O: 0.4%
H: 1.16%
C: -6.33%
new drug fda application phase 1 gene therapy therapy drug trial submission
Curis Announces First Patient Dosed in Phase 1/2 Study of CA-4948 Combination Therapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Published: 2021-11-08 (Crawled : 15:00) - biospace.com/
CRIS | $14.51 -4.67% 4.8K
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: -5.35%
myeloid leukemia risk phase 1 therapy leukemia syndros ca-4948 acute myeloid leukemia
Pieris Pharmaceuticals and Servier Announce Dosing of First Patient in Phase 1/2 Trial of 4-1BB/PD-L1 Bispecific PRS-344/S095012
Published: 2021-11-08 (Crawled : 14:00) - biospace.com/
PIRS | $0.1431 -7.8% 1.6M
|
Health Technology
|
| O: 0.7%
H: 1.86%
C: -3.26%
phase 1 trial
DiaMedica Therapeutics Announces Addition of Stroke Recurrence as a Second Independent Primary Endpoint in ReMEDy2 Phase 2/3 AIS Trial
Published: 2021-11-08 (Crawled : 14:00) - biospace.com/
DMAC | $2.46 -1.21% 15K
|
Health Technology
|
| O: 2.8%
H: 0.42%
C: -3.77%
stroke phase 2 phase 2/3 trial
Alnylam Initiates KARDIA-2 Phase 2 Study of Investigational Zilebesiran (ALN-AGT) in Patients with Inadequately Controlled Hypertension
Published: 2021-11-08 (Crawled : 13:00) - biospace.com/
ALNY | News | $145.89 0.5% 170K
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: 0.0%
phase 2 hypertension
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.